US2016303374A1PendingUtilityA1

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

Assignee: NEVRO CORPPriority: Apr 22, 2009Filed: Apr 20, 2016Published: Oct 20, 2016
Est. expiryApr 22, 2029(~2.7 yrs left)· nominal 20-yr term from priority
A61N 1/3616A61N 1/36075A61N 1/3605A61N 1/3787A61N 1/36182A61N 1/36071A61N 1/0553A61N 1/36164A61N 1/36021A61N 1/37241A61N 1/36171A61N 1/37235A61N 1/36167A61N 1/36128A61N 1/36175A61N 1/37264A61N 1/37247A61N 1/36062A61N 1/06A61N 1/36157A61N 1/0551A61N 1/326A61N 1/36089A61N 1/323A61N 1/36132A61N 1/36178G01R 21/133
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region to address low back pain without creating unwanted sensory and/or motor side effects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Claims

exact text as granted — not AI-modified
1 - 137 . (canceled) 
     
     
         138 . A spinal cord modulation system for reducing or eliminating pain in a patient, the system comprising:
 a signal generator configured to generate a therapy signal producing no sensory effect other than to reduce or eliminate pain, wherein at least a portion of the therapy signal is at a frequency in a frequency range from 1.5 kHz to 100 kHz; and   an implantable signal delivery device electrically coupleable to the signal generator and configured to deliver the therapy signal to the patient's spinal cord region.   
     
     
         139 . The system of  claim 138  wherein the signal delivery device is a paddle lead configured to be implanted in a target location. 
     
     
         140 . The system of  claim 138  wherein the signal delivery device is an elongated lead having one or more electrodes configured to direct the therapy signal to a target location. 
     
     
         141 . The system of  claim 138  wherein the signal generator is an implantable signal generator. 
     
     
         142 . The system of  claim 138  wherein at least a portion of the therapy signal has a pulse width in a pulse width range from 10 microseconds to 333 microseconds. 
     
     
         143 . The system of  claim 138  wherein at least a portion of the therapy signal has a pulse width in a pulse width range from 25 microseconds to 166 microseconds. 
     
     
         144 . The system of  claim 138  wherein at least a portion of the therapy signal has a pulse width in a pulse width range from 30 microseconds to 35 microseconds. 
     
     
         145 . The system of  claim 138  wherein the frequency range is from 1.5 kHz to 50 kHz. 
     
     
         146 . The system of  claim 138  wherein the frequency range is from 3 kHz to 20 kHz. 
     
     
         147 . The system of  claim 138  wherein at least a portion of the therapy signal has a current amplitude in a current amplitude range from 0.5 to 10 mA. 
     
     
         148 . The system of  claim 138  wherein the frequency range is from 3 to 20 kHz, and wherein a pulse width of the therapy signal is in a pulse width range from 10 to 333 microseconds, and wherein a current amplitude of the therapy signal is in a current amplitude range from 0.5 mA to 10 mA. 
     
     
         149 . The system of  claim 138  wherein the signal generator is programmed with instructions for generating the therapy signal. 
     
     
         150 . The system of  claim 138  wherein at least a portion of the therapy signal is a square-wave signal. 
     
     
         151 . The system of  claim 138  wherein the signal generator generates the therapy signal at a duty cycle of less than 100%. 
     
     
         152 . A spinal cord modulation system for reducing or eliminating pain in a patient without creating a sensory effect other than reducing or eliminating pain in the patient, the system comprising:
 an implantable signal generator configured to generate a therapy signal producing no sensory effect other than to reduce or eliminate pain in the patient, wherein at least a portion of the therapy signal is a biphasic square-wave signal, at a frequency in a frequency range from 1.5 kHz to 100 kHz, and at a current amplitude of less than about 20 mA; and   a signal delivery device electrically coupleable to the implantable signal generator and configured to deliver the therapy signal to the patient's spinal cord region.   
     
     
         153 . The system of  claim 152  wherein the signal delivery device is an implantable signal delivery device. 
     
     
         154 . The system of  claim 152  wherein the signal delivery device is a paddle lead configured to be implanted in a target location. 
     
     
         155 . The system of  claim 152  wherein the signal delivery device is an elongated lead having one or more electrodes configured to direct the therapy signal to a target location. 
     
     
         156 . The system of  claim 152  wherein at least a portion of the therapy signal has a pulse width in a pulse width range from 10 microseconds to 333 microseconds. 
     
     
         157 . The system of  claim 152  wherein at least a portion of the therapy signal has a pulse width in a pulse width range from 30 microseconds to 35 microseconds. 
     
     
         158 . The system of  claim 152  wherein the frequency range is from 3 kHz to 20 kHz. 
     
     
         159 . The system of  claim 152  wherein the therapy signal has a current amplitude in a current amplitude range from 0.5 to 10 mA. 
     
     
         160 . The system of  claim 152  wherein the frequency range is from 3 to 20 kHz, and wherein a pulse width of the therapy signal is in a pulse width range from 10 to 333 microseconds, and wherein a current amplitude of the therapy signal is in a current amplitude range from 0.5 mA to 10 mA. 
     
     
         161 . A method for configuring a spinal cord stimulation system to deliver a therapy signal to a patient's spinal cord, the method comprising:
 programming the spinal cord stimulation system to
 (1) generate a therapy signal, wherein at least a portion of the therapy signal has a frequency in a frequency range from 1.5 kHz to 100 kHz and does not create a sensory effect other than to reduce or eliminate pain in the patient; and 
 (2) deliver the therapy signal to the patient's spinal cord via an implantable signal delivery device. 
   
     
     
         162 . The method of  claim 161 , further comprising programming the spinal cord stimulation system to deliver the therapy signal to a vertebral level between T9 and T12, inclusively. 
     
     
         163 . The method of  claim 161 , further comprising programming the spinal cord stimulation system to deliver the therapy signal to a thoracic vertebral level. 
     
     
         164 . The method of  claim 161 , further comprising programming the spinal cord stimulation system to deliver the therapy signal to a vertebral level between C3 and C7, inclusively. 
     
     
         165 . The method of  claim 161  wherein the frequency range is between 3 kHz and 20 kHz. 
     
     
         166 . The method of  claim 161  wherein the frequency range is between 5 kHz and 15 kHz. 
     
     
         167 . The method of  claim 161  wherein the frequency is 10 kHz. 
     
     
         168 . The method of  claim 161  wherein the frequency range is from 3 kHz and 20 kHz, and wherein a pulse width of the therapy signal is in a pulse width range from 10 to 333 microseconds, and wherein a current amplitude of the therapy signal is in a current amplitude range from 0.5 mA to 10 mA. 
     
     
         169 . A method for treating a patient, comprising:
 delivering an electrical therapy signal to the patient's spinal cord via at least one implanted signal delivery device to reduce or eliminate pain in the patient without producing a sensory effect other than to reduce or eliminate the pain, the signal having a frequency in a frequency range from 1.5 kHz to 100 kHz.   
     
     
         170 . The method of  claim 169 , further comprising:
 placing or instructing placement of the at least one signal delivery device at a position along the spinal cord as at least part of a placement process, without using patient feedback during the placement process to at least assist in selecting the position.   
     
     
         171 . The method of  claim 169  the electrical therapy signal reduces or eliminates both low-back pain and leg pain. 
     
     
         172 . The method of  claim 169  wherein the frequency range is from 3 kHz to 20 kHz. 
     
     
         173 . The method of  claim 169  wherein the frequency range is from 5 kHz to 15 kHz. 
     
     
         174 . The method of  claim 169  wherein the frequency range is from 3 kHz to 20 kHz, and wherein a pulse width of the therapy signal is in a pulse width range from 10 to 333 microseconds, and wherein a current amplitude of the therapy signal is in a current amplitude range from 0.5 mA to 10 mA. 
     
     
         175 . A method for treating a patient, comprising:
 delivering or instructing delivery of an electrical signal to the patient's spinal cord via at least one implantable signal delivery device; and   wherein the electrical signal has a frequency in a frequency range from 1.5 kHz to 100 kHz and does not create a sensory effect other than to reduce or eliminate pain in the patient.   
     
     
         176 . The method of  claim 175  wherein the frequency range is between 3 kHz and 20 kHz. 
     
     
         177 . The method of  claim 175  wherein the frequency range is between 5 kHz and 15 kHz. 
     
     
         178 . The method of  claim 175  wherein the frequency is 10 kHz. 
     
     
         179 . The method of  claim 175  wherein the frequency range is from 3 kHz and 20 kHz, and wherein a pulse width of the therapy signal is in a pulse width range from 10 to 333 microseconds, and wherein a current amplitude of the therapy signal is in a current amplitude range from 0.5 mA to 10 mA.

Join the waitlist — get patent alerts

Track US2016303374A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.